- Home
- ALDX vs BLNK Comparison
ALDX vs BLNK Comparison
Compare ALDX & BLNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- BLNK
- Stock Information
- Founded
- ALDX 2004
- BLNK 2009
- Country
- ALDX United States
- BLNK United States
- Employees
- ALDX N/A
- BLNK N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- BLNK Industrial Specialties
- Sector
- ALDX Health Care
- BLNK Consumer Discretionary
- Exchange
- ALDX Nasdaq
- BLNK Nasdaq
- Market Cap
- ALDX 319.4M
- BLNK 295.1M
- IPO Year
- ALDX 2014
- BLNK N/A
- Fundamental
- Price
- ALDX $4.85
- BLNK $1.53
- Analyst Decision
- ALDX Strong Buy
- BLNK Buy
- Analyst Count
- ALDX 2
- BLNK 7
- Target Price
- ALDX $10.00
- BLNK $5.64
- AVG Volume (30 Days)
- ALDX 571.6K
- BLNK 5.4M
- Earning Date
- ALDX 11-07-2024
- BLNK 11-07-2024
- Dividend Yield
- ALDX N/A
- BLNK N/A
- EPS Growth
- ALDX N/A
- BLNK N/A
- EPS
- ALDX N/A
- BLNK N/A
- Revenue
- ALDX N/A
- BLNK $138,728,000.00
- Revenue This Year
- ALDX N/A
- BLNK $6.03
- Revenue Next Year
- ALDX $25.36
- BLNK $30.95
- P/E Ratio
- ALDX N/A
- BLNK N/A
- Revenue Growth
- ALDX N/A
- BLNK 15.13
- 52 Week Low
- ALDX $2.43
- BLNK $1.48
- 52 Week High
- ALDX $6.55
- BLNK $4.48
- Technical
- Relative Strength Index (RSI)
- ALDX 45.59
- BLNK 37.11
- Support Level
- ALDX $4.66
- BLNK $1.48
- Resistance Level
- ALDX $5.01
- BLNK $1.62
- Average True Range (ATR)
- ALDX 0.40
- BLNK 0.13
- MACD
- ALDX -0.01
- BLNK -0.04
- Stochastic Oscillator
- ALDX 46.06
- BLNK 7.35
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns majority revenue from U.S.A.